₹580 Cr
₹43 Cr
13.59
As on 07-Jun-2023 IST
₹0.55
•
0.20%
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Windlas Biotech
| 11.70 | 9.44 | 10.74 | 22.28 | -- | -- | -- |
|
S&P BSE Healthcare
| 6.08 | 5.62 | 12.19 | 10.80 | 14.78 | 13.70 | 10.63 |
|
S&P BSE Small Cap
| 9.01 | 7.68 | 12.24 | 20.17 | 38.56 | 13.88 | 18.11 |
|
2022
|
|
|---|---|
|
Windlas Biotech
| -9.37 |
|
S&P BSE Small Cap
| -1.80 |
|
S&P BSE Healthcare
| -12.10 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
₹580.18 Cr
₹513.08 Cr
₹42.63 Cr
₹131.97 Cr
₹6.12 Cr
62.38%
High
₹203.25 - 287.70
₹5.00
2,07,98,575
BSE: 543329, NSE: WINDLAS
Dehradun, Uttarakhand
www.windlasbiotech.com
Windlas Biotech Limited, contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India. It offers CDMO services, including product discovery, product development, licensing, and commercial... manufacturing of generic products. The company also provides manufactures various domestic trade generics and over-the-counter brands, which include nutraceutical and health supplement products through the online and offline channels. In addition, it manufactures pills, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. It exports its products primarily to Cambodia, Ivory Coast, the Philippines, Thailand, Vietnam, Myanmar, and Sri Lanka. The company was incorporated in 2001 and is based in Gurugram, India. Read more
Share via Facebook 
Share via Twitter 
Share via LinkedIn 
Share this
Add Portfolio